Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated125%
active_not_recruiting125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

EMPOWER AUD Pivotal Trial

NCT05948605
terminatednot_applicable

Empower Neuromodulation System - Pilot Study for Anxiety Treatment

NCT04901481
active_not_recruitingnot_applicable

Pilot Research on Opioid Use Disorder

NCT04244227
completednot_applicable

Pilot Evaluation of the Empower Neuromodulation System in AUD Patients

NCT03983317

Clinical Trials (4)

Showing 4 of 4 trials
NCT05948605Not Applicable

EMPOWER AUD Pivotal Trial

Completed
NCT04901481Not Applicable

Empower Neuromodulation System - Pilot Study for Anxiety Treatment

Terminated
NCT04244227Not Applicable

Pilot Research on Opioid Use Disorder

Active Not Recruiting
NCT03983317Not Applicable

Pilot Evaluation of the Empower Neuromodulation System in AUD Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4